The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumInsights - Almost three years after an initial collaboration was announced, AstraZeneca (AZN) has selected the first clinical candidate from a discovery program with Regulus Therapeutics (RGLS). RGLS jumped … Continue Reading
Read nowResearch - Our suggestion in November was to be long GBIM from below $6.00 in anticipation of data this quarter for GS-4774. We're up 75%. Here's what to do next.
PremiumResearch - Great news for our suggested uniQure (QURE) position – Bristol-Myers Squibb (BMY) is putting up $100 million upfront to partner with the European gene therapy developer … Continue Reading
PremiumResearch - Trillium Therapeutics raised approximately $50 million in a secondary offering this week. The company is well-financed through 2016 and initial (critical) data on lead program, SIRPaFc. … Continue Reading
PremiumInsights - Dyax Corp. (DYAX) saw a gain of over 40% in pre-market trading Wednesday with the release of phase 1b results for DX-2930, an inhibitor of … Continue Reading
Read nowInsights - Monday morning was jam-packed with deal flow in biotech. Here's a 60-second primer.
Read now
